MyStroke Educational Platform for Stroke Management

Overseen By Christopher G Favilla, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Pennsylvania

Disqualifiers: Severe aphasia, complete dependence, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 90 days

100 Participants Needed

Trial Summary

What is the purpose of this trial?

This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.

Eligibility Criteria

This trial is for adults who had an ischemic stroke between 1 and 10 years ago, are getting outpatient care at the University of Pennsylvania Hospital, can use a smart device or computer, and are willing to do follow-up surveys. It's not for those who can't use the app, need full-time caregiver help, had their stroke outside the 1-10 year window, or have severe speech difficulties.

Inclusion Criteria

I am 18 years old or older.

I am willing to complete two surveys after joining the study.

I am getting outpatient stroke care at the University of Pennsylvania Hospital.

Exclusion Criteria

I rely completely on someone else for daily tasks.

Unwilling or unable to access the customized app with a smartphone, tablet, or computer

My stroke happened less than 1 year ago or over 10 years ago.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either personalized video-based stroke education or standard education

90 days

Follow-up

Participants are monitored for stroke knowledge retention and satisfaction

90 days

Treatment Details

Interventions

• MyStroke

Trial Overview The MyStroke clinical trial tests a personalized video-based educational platform designed to improve patient satisfaction and knowledge about chronic stroke management. Participants will be randomly assigned to either receive this intervention or not.

Participant Groups

Group I: MyStroke Experimental Treatment 1 Intervention

Access to a personalized video-based stroke educational platform

Group II: Standard Education Active Control 1 Intervention

Standard stroke patient education as per the medical providers

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials

2,118

Recruited

45,270,000+